Table 4.
COPD Exacerbations* | Respiratory-Related Emergency Utilization* | All-Cause Mortality† | |
---|---|---|---|
OR (95% CI) p-value | OR (95% CI) p-value | HR (95% CI) p-value | |
Model 1: Controlling for Sociodemographics + BMI | 4.7 (1.3 – 17) p = 0.018 | 11.5 (2.1 – 62) p = 0.004 | 5.0 (1.4 – 18) p = 0.013 |
Model 2: Model 1 + FEV1 | 6.3 (1.6 – 25) p = 0.008 | 15.2 (2.5 – 91) p = 0.003 | 9.5 (2.1 – 44) p = 0.004 |
Model 3: Model 1 + FEV1 + COPD Severity Score | 4.0 (1.1 – 15) p = 0.042 | 9.7 (1.5 – 63) p = 0.017 | 8.8 (1.8 – 43) p = 0.007 |
All of the estimates (hazard ratio [HR] or odds ratio [OR]) presented above are for the association between sleep disturbance and a given health outcome (COPD exacerbations, or emergency utilization, all-cause mortality), with each of the 3 models controlling for an increasing number of covariates.
Analyses of COPD exacerbations and emergency utilization were multivariable logistic regressions in which the outcome was assessed one year after baseline. Emergency utilization is the combined end-point of either a hospitalization or ED visit.
Analyses of all-cause mortality were multivariable Cox regression analysis in which the outcome was assessed over a median 2.4 years of follow-up.
Model 1 controls for age, gender, race, marital status, educational attainment, and BMI
Model 2 controls for all variables in Model 1 + FEV1 (absolute)
Model 3 controls for all variables in Model 1 + FEV1 (absolute) + COPD Severity Score